Lung cavitation in COVID-19: co-infection complication or rare evolution?

Amaral, Lucas Tadashi Wada; Beraldo, Gabriel Laverdi; Brito, Vanessa Mizubuti; Rosa, Marcela Emer Egypto; Matos, Marina Justi Rosa de; Fonseca, Eduardo Kaiser Ururahy Nunes; Yokoo, Patrícia; Silva, Murilo Marques Almeida; Teles, Gustavo Borges da Silva; Shoji, Hamilton; Passos, Rodrigo Bastos Duarte; Chate, Rodrigo Caruso; Szarf, Gilberto

doi:10.31744/einstein_journal/2020ai5822

Cited by 17 publications

(12 citation statements)

References 4 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…None had received prior immunosuppression. All 12 were males, required invasive mechanical ventilation, and the median (range) time from symptom onset to invasive mechanical ventilation was 8 (3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15) days. Three were admitted directly via our institution's Emergency Department and intubated within 24 hours, and nine patients were transferred from other hospitals within 72 hours of intubation.…”

Section: Resultsmentioning

confidence: 99%

Pulmonary cavitation – an under-recognized late complication of severe COVID-19 lung disease

Zoumot

Bonilla

Wahla

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Pulmonary radiological findings of the novel coronavirus disease 2019 (COVID-19) have been well documented and range from scattered ground-glass infiltrates in milder cases to confluent ground-glass change, dense consolidation, and crazy paving in the critically ill. However, lung cavitation has not been commonly described in these patients. The objective of this study was to assess the incidence of pulmonary cavitation in patients with COVID-19 and describe its characteristics and evolution. Methods: We conducted a retrospective review of all patients admitted to our institution with COVID-19 and reviewed electronic medical records and imaging to identify patients who developed pulmonary cavitation. Results: Twelve out of 689 (1.7%) patients admitted to our institution with COVID-19 developed pulmonary cavitation, comprising 3.3% (n=12/359) of patients who developed COVID-19 pneumonia, and 11% (n=12/110) of those admitted to the intensive care unit. We describe the imaging characteristics of the cavitation and present the clinical, pharmacological, laboratory, and microbiological parameters for these patients. In this cohort six patients have died, and six discharged home. Conclusion: Cavitary lung disease in patients with severe COVID-19 disease is not uncommon, and is associated with a high level of morbidity and mortality.

show abstract

Section: Resultsmentioning

confidence: 99%

Pulmonary cavitation – an under-recognized late complication of severe COVID-19 lung disease

Zoumot

Bonilla

Wahla

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Zantah et al [ 186 ] reported six cases of SPX in 902 patients with COVID-19 pneumonia with an incidence of 0.66%. Lung cavitations have also been reported as rare complications in COVID-19 pneumonia and can be due to cavitation of pulmonary infarctions or caused by destructive pulmonary fibrosis in the late phase of the disease, or associated with necrotizing pneumonia [ 194 , 195 ].…”

Section: Covid-19 Complicationsmentioning

confidence: 99%

A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia

Brogna

Bignardi

Brogna³

et al. 2021

Diagnostics

View full text Add to dashboard Cite

Imaging plays an important role in the detection of coronavirus (COVID-19) pneumonia in both managing the disease and evaluating the complications. Imaging with chest computed tomography (CT) can also have a potential predictive and prognostic role in COVID-19 patient outcomes. The aim of this pictorial review is to describe the role of imaging with chest X-ray (CXR), lung ultrasound (LUS), and CT in the diagnosis and management of COVID-19 pneumonia, the current indications, the scores proposed for each modality, the advantages/limitations of each modality and their role in detecting complications, and the histopathological correlations.

show abstract

“…A small number published single patient case reports have more recently reported pulmonary cavitation [10][11][12] , but this is considered a rare event. In contrast, experience at our tertiary care referral hospital differed.…”

Section: Introductionmentioning

confidence: 99%

Pulmonary cavitation – an under-recognized late complication of severe COVID-19 lung disease

Zoumot

Bonilla

Wahla

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Pulmonary radiological findings of the novel coronavirus disease 2019 (COVID-19) have been well documented and range from scattered ground-glass infiltrates in milder cases to confluent ground-glass change, dense consolidation, and crazy paving in the critically ill. However, lung cavitation has not been commonly described in these patients. The objective of this study was to assess the incidence of pulmonary cavitation in patients with COVID-19 and describe its characteristics and evolution.Methods: We conducted a retrospective review of all patients admitted to our institution with COVID-19 and reviewed electronic medical records and imaging to identify patients who developed pulmonary cavitation.Results: Twelve out of 689 (1.7%) patients admitted to our institution with COVID-19 developed pulmonary cavitation, comprising 3.3% (n=12/359) of patients who developed COVID-19 pneumonia, and 11% (n=12/110) of those admitted to the intensive care unit. We describe the imaging characteristics of the cavitation and present the clinical, pharmacological, laboratory, and microbiological parameters for these patients. In this cohort six patients have died, and six discharged home. Conclusion: Cavitary lung disease in patients with severe COVID-19 disease is not uncommon, and is associated with a high level of morbidity and mortality.

show abstract

Lung cavitation in COVID-19: co-infection complication or rare evolution?

Abstract: Figure 2. Bedside anteroposterior chest X-ray images demonstrate the radiographic evolution of the nosocomial infection with multiple areas of consolidation in both lungs

Cited by 17 publications

References 4 publications

Pulmonary cavitation – an under-recognized late complication of severe COVID-19 lung disease

Pulmonary cavitation – an under-recognized late complication of severe COVID-19 lung disease

A Pictorial Review of the Role of Imaging in the Detection, Management, Histopathological Correlations, and Complications of COVID-19 Pneumonia

Pulmonary cavitation – an under-recognized late complication of severe COVID-19 lung disease

Contact Info

Product

Resources

About